Newsroom

Logo
News
NFDI4Microbiota celebrates success in second round of NFDI calls
NFDI4Microbiota is set to become part of Germany’s national research data infrastructure (NFDI). In May 2021, a panel of experts recommended that the consortium should receive NFDI funding – and now the Joint Science Conference (GWK) has given its approval. The German Research Foundation (DFG) will fund the National Research Data Infrastructure for Microbiota Research – to give the consortium its full title – for an initial period of five years. NFDI4Microbiota’s mission is to support the microbiology research community in Germany by providing access to data, data analysis tools, and data and metadata standards, as well as a comprehensive range of training programmes.
02.07.2021
HZI Campus
BRICS
Portrait
News
HZI appoints Fabian Leendertz as founding director of the Helmholtz Institute for One Health
The Helmholtz Centre for Infection Research (HZI) has appointed PD Dr Fabian Leendertz as founding director of the Helmholtz Institute for One Health (HIOH) in Greifswald on 26 May 2021. At the same time, he accepted his appointment to a W3 professorship for One Health at the University of Greifswald and is expected to become a university professor on 1 August 2021. As another site of the HZI, the HIOH will in future cooperate closely with the University of Greifswald, Greifswald University Hospital and the Friedrich Loeffler Institute. One Health involves interdisciplinary research at the interface of human health, animal health and the environment.
16.06.2021
HIOH
Vero6-Zellen infiziert mit SARS-CoV-2
News
Helmholtz researches holistic solutions for pandemic response
How can we apply the knowledge we have gained so far to better overcome the current crisis and prevent another pandemic in future? Helmholtz aims to find answers to these questions with two new, interdisciplinary collaborative projects. In addition to the holistic approach, the focus is also on quickly implementing the results into practice.
20.05.2021
HZI Campus
News
CRISPR discovery from Würzburg paves the way for novel COVID testing method
Am I infected with SARS-CoV-2? Is it one of the dangerous variants? Being able to answer these and more questions with a single efficient diagnostic test can be decisive for gauging the spread of disease and selecting the right therapy. In a study published today in the journal "Science", researchers from Würzburg at the Helmholtz Institute for RNA-based Infection Research (HIRI), a site of the Helmholtz Centre for Infection Research (HZI) in cooperation with the Julius Maximilians University (JMU), tackle this challenge with a new CRISPR discovery they translated into a diagnostic platform called LEOPARD.
27.04.2021
HIRI
Scanning electron microscope image of Mycobacterium tuberculosis.
Interview
World Tuberculosis Day 2021: New drugs for old bugs
On the occasion of World Tuberculosis Day, Jennifer Herrmann, scientist in the department Microbial Natural Products at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), talks about the epidemiology of the disease and her current research into new active substances against the causative agent of tuberculosis.
23.04.2021
HIPS
Illustration
News
How well are we protected six months after infection or vaccination?
After exposure to a virus through infection or vaccination, the body activates a number of cells and mechanisms that can provide targeted defense against the pathogen. For the global containment of the SARS-CoV-2 pandemic, the question of how long this protection lasts is an important factor. Prof Carlos Guzmán, vaccine researcher at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany, summarizes what is known about long-term immunity to SARS-CoV-2 and what difference it makes whether immunity is acquired through vaccination or infection.
08.04.2021
HZI Campus

HZI in the media

Studie enthüllt versteckte Gefahr: Neue Erkenntnisse zu tödlichem Bakterium

... außerhalb des Magen-Darm-Traktes zu überleben. Das Helmholtz Zentrum für Infektionsforschung (HZI) bezeichnet die Clostridien als „ ...

12.05.2025
|
Frankfurter Rundschau online
Bakterien: Erfassung der Genaktivität effizienter gemacht

Maximilians-Universität (JMU) Würzburg und des Würzburger Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI) haben 2020 eine ...

11.05.2025
|
Medizin Aspekte
Saarland: 3000 Quadratmeter-Rohbau wird innerhalb von acht Tagen errichtet

Im Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) in Saarbrücken wird Spitzenforschung betrieben. Jetzt bekommt ...

09.05.2025
|
Tagesschau
Bacteria: A Breakthrough in Efficient Gene Activity Recording

JMU) Würzburg, in cooperation with the Helmholtz Institute for RNA-based Infection Research (HIRI), have developed and refined a cutting-

08.05.2025
|
Bioengineer.org
When citizens are researching

In the “Microbelix” project from the Helmholtz Institute for Pharmaceutical Research in Saarland, citizens can send soil samples from

08.05.2025
|
techzle
Under the super microscope: How influenza viruses communicate with cells

triggers of future pandemics. A research team from the Helmholtz Center for Infection Research (HZI) and the Medical Center—University of

07.05.2025
|
Phys.org